Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0JA4K
|
|||
Drug Name |
PMID27841036-Compound-36
|
|||
Drug Type |
Small molecular drug
|
|||
Company |
MGI GP, INC. XU, Weizheng DELAHANTY, Greg ZHANG, Jie
|
|||
Structure |
Download2D MOL |
|||
Formula |
C20H19N3O3
|
|||
Canonical SMILES |
C1CN(CCC1O)CC2=CC3=C(C=C2)OC4=CC=CC5=C4C3=NNC5=O
|
|||
InChI |
1S/C20H19N3O3/c24-13-6-8-23(9-7-13)11-12-4-5-16-15(10-12)19-18-14(20(25)22-21-19)2-1-3-17(18)26-16/h1-5,10,13,24H,6-9,11H2,(H,22,25)
|
|||
InChIKey |
HAVFFEMDLROBGI-UHFFFAOYSA-N
|
|||
CAS Number |
CAS 902128-92-1
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Poly [ADP-ribose] polymerase (PARP) | Target Info | Inhibitor | [1] |
Target's Patent Info | Poly [ADP-ribose] polymerase (PARP) | Target's Patent Info | [1] |
References | Top | |||
---|---|---|---|---|
REF 1 | PARP inhibitors as antitumor agents: a patent update (2013-2015).Expert Opin Ther Pat. 2017 Mar;27(3):363-382. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.